Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
34.00
+1.61 (4.97%)
Jan 31, 2025, 4:00 PM EST - Market closed
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $229.81 million as of January 31, 2025. Its market cap has increased by 1,399.78% in one year.
Market Cap
229.81M
Enterprise Value
225.94M
1-Year Change
1,399.78%
Ranking
Category
Stock Price
$34.00
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $229.81M, an increase of 450.01%. That is a compound annual growth rate of 53.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 229.81M | -8.31% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.02B |
| UnitedHealth Group | 495.21B |
| Novo Nordisk | 376.62B |
| Johnson & Johnson | 363.91B |
| AbbVie | 309.71B |
| Merck & Co. | 248.61B |
| Abbott Laboratories | 221.77B |
| Thermo Fisher Scientific | 217.35B |